Highlights from this issue
Perception of lung function, adherence to inhaled corticosteroids, and the role of peak expiratory flow feedback in paediatric asthma
Obstructive sleep apnoea and metabolic syndrome
The president speaks
Low levels of tissue factor lead to alveolar haemorrhage, potentiating murine acute lung injury and oxidative stress
Prediction of peak flow values followed by feedback improves perception of lung function and adherence to inhaled corticosteroids in children with asthma
Multifaceted allergen avoidance during infancy reduces asthma during childhood with the effect persisting until age 18 years
The at-risk registers in severe asthma (ARRISA) study
Scadding-Morriston Davies joint fellowship in respiratory medicine 2013
Epithelial eotaxin-2 and eotaxin-3 expression
Increased circulating endothelial microparticles in COPD patients
Host genotype-specific therapies for tuberculosis
Changes in prevalence and load of airway bacteria using quantitative PCR in stable and exacerbated COPD
Cardiometabolic changes after continuous positive airway pressure for obstructive sleep apnoea
Continuous positive airway pressure improves sleepiness but not calculated vascular risk in patients with minimally symptomatic obstructive sleep apnoea
Therapeutic advances in non-small cell lung cancer
Prospects for the development of effective pharmacotherapy targeted at the skeletal muscles in chronic obstructive pulmonary disease
Are early life factors considered when managing respiratory disease? A British Thoracic Society survey of current practice
Assessment of intraparenchymal lung collateral ventilation
Authors' response to assessment of intraparenchymal lung collateral ventilation
Lung cancer risk in subjects exposed to organic dust
Authors' response
New cell for asthma
A puzzling tumour
Your asthma reliever inhaler
Heterotopic ossification encasing a plombage cavity
Management of latent tuberculosis infection
In digging up the past of this 90-year-old man, a recent Eastern European immigrant to the USA, what is a historical treatment for an ongoing endemic disease he might have received?